PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Avastin (Bevacizumab)- FDA 207 Drug Drug Aflibercept (Eylea)- FDA 14 6 0.11 -0.74 0.43 0.82
Arimidex (Anastrozole)- FDA 10 Drug Drug Aromasin (Exemestane)- FDA 7 3 0.36 -0.63 0.43 0.93
Aromasin (Exemestane)- FDA 7 Drug Drug Anastrozole (Arimidex)- FDA 10 3 0.36 -0.63 0.43 0.93
Anxiety 113,510 Disease Disease Somatoform Disorder 479 206 0.03 -0.75 0.43 0.66
Acute Migraine 946 Disease Disease Pain 409,851 407 0.02 -0.75 0.43 0.63
Infection 766,637 Disease Disease Pinworm 367 158 0.01 -0.75 0.43 0.60
Cancer 1,053,491 Disease Disease Lung Carcinoma 13,423 5,796 0.05 -0.75 0.43 0.63
Infection 766,637 Disease Disease Genital Warts 1,791 778 0.02 -0.75 0.43 0.61
Acne 11,364 Disease Drug Accutane (Isotretinoin)- FDA 39 17 0.03 -0.75 0.44 0.69
Social Anxiety 3,287 Disease Disease Anxiety Disorder 8,985 1,436 0.26 -0.69 0.44 0.85
Alemtuzumab (Campath)- FDA 32 Drug Disease Leukemia 162,805 14 0.01 -0.75 0.44 0.62
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Target Antithrombin 13,773 7 0.01 -0.75 0.44 0.67
Chronic Lymphocytic Leukemia 11,642 Disease Drug Alemtuzumab (Campath)- FDA 32 14 0.02 -0.75 0.44 0.69
Separation Anxiety 1,096 Disease Disease Anxiety Disorder 8,985 482 0.15 -0.73 0.44 0.80
Anxiety 113,510 Disease Target Neuropeptide S Receptor 77 34 0.01 -0.75 0.44 0.63
Cancer 1,053,491 Disease Target Kallikrein-6 79 35 0.00 -0.75 0.44 0.58
CINC-2- alpha 9 Target Disease Inflammation 252,734 4 0.00 -0.75 0.44 0.59
Abatacept (Orencia)- FDA 18 Drug Disease Rheumatoid Arthritis 78,952 8 0.01 -0.75 0.44 0.63
Irritable Bowel Syndrome 8,230 Disease Drug Alosetron Hydrochloride (Lotronex)- FDA 27 12 0.03 -0.74 0.44 0.70
CCL5 2,002 Target Target CXCL4/PF4 9 4 0.03 -0.74 0.44 0.72
CXCL10/IP-10 114 Target Target CXCL4/PF4 9 4 0.12 -0.73 0.44 0.83
Doxorubicin-Formaldehyde Conjugate 9 Drug Drug Doxoform 9 4 0.44 -0.56 0.44 0.95
Cryoglobulinemia 2,693 Disease Disease Hepatitis 163,842 1,197 0.06 -0.74 0.44 0.68
Cancer 1,053,491 Disease Target EPHA2 532 239 0.01 -0.74 0.45 0.59
Depression 220,092 Disease Disease Mania 7,698 3,463 0.08 -0.74 0.45 0.70
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
Droxidopa 40 Drug Disease Hypotension 42,123 18 0.01 -0.74 0.45 0.66
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
Vascular Cell Adhesion Protein 1 31 Target Disease Inflammation 252,734 14 0.01 -0.74 0.45 0.60
Seizure 44,685 Disease Disease Epilepsy 71,172 20,202 0.36 -0.63 0.45 0.86
Pneumonia 81,521 Disease Drug Atovaquone (Mepron)- FDA 11 5 0.01 -0.74 0.45 0.62
Poisoning 53,779 Disease Drug Atropine (Atropen)- FDA 11 5 0.01 -0.74 0.45 0.63
Poisoning 53,779 Disease Drug Atropen (Atropine)- FDA 11 5 0.01 -0.74 0.45 0.63
Schizophrenia 77,034 Disease Target Metabotropic Glutamate Receptor 3 55 25 0.01 -0.74 0.45 0.64
Diabetes 332,602 Disease Target Exendin-4 855 392 0.02 -0.74 0.46 0.63
Cancer 1,053,491 Disease Target DAPK1 205 94 0.01 -0.74 0.46 0.58
Retinoic Acid Receptor Alpha 1,068 Target Disease Leukemia 162,805 490 0.04 -0.73 0.46 0.66
Thrombocytopenia 35,805 Disease Drug Angiomax (Bivalirudin)- FDA 13 6 0.01 -0.73 0.46 0.65
Diabetes 332,602 Disease Disease Albuminuria 6,831 3,164 0.07 -0.73 0.46 0.67
Erbb2 4,536 Target Target ERBB4 994 461 0.22 -0.69 0.46 0.83
Cancer 1,053,491 Disease Disease Familial Adenomatous Polyposis 3,742 1,737 0.03 -0.73 0.46 0.61
Myelodysplastic Syndrome 7,378 Disease Disease Leukemia 162,805 3,433 0.10 -0.72 0.47 0.71
CCL2 3,560 Target Target CCL8 197 92 0.11 -0.72 0.47 0.78
Cancer 1,053,491 Disease Target BRAF 4,766 2,231 0.03 -0.73 0.47 0.62
Seborrhea 430 Disease Disease Acne 11,364 202 0.09 -0.72 0.47 0.75
Sentinel Lymph Node Biopsy 3,064 Disease Disease Breast Cancer 173,695 1,448 0.06 -0.72 0.47 0.68
Phobias 1,578 Disease Disease Anxiety 113,510 751 0.06 -0.72 0.48 0.69
Diabetes 332,602 Disease Disease Dyslipidemia 15,225 7,305 0.10 -0.71 0.48 0.70
Carcinoma Bladder 25 Disease Disease Cancer 1,053,491 12 0.00 -0.72 0.48 0.57
Carcinoma Bladder 25 Disease Disease Bladder Cancer 21,509 12 0.02 -0.72 0.48 0.67